NEW YORK–(BUSINESS WIRE)–$BMY–The Board of Directors of Bristol-Myers
Squibb Company (NYSE:BMY) today declared an increase of 2.5% percent
in the company’s quarterly dividend, beginning in the first quarter of
The dividend increase will result in a quarterly dividend of 41 cents
($0.41) per share on the $.10 par value Common Stock of the corporation.
The next quarterly dividend will be payable on February 1, 2019, to
stockholders of record at the close of business on January 4, 2019.
The directors also declared a quarterly dividend of fifty cents ($0.50)
per share on the $2.00 Convertible Preferred Stock of the corporation,
payable March 1, 2019 to stockholders of record at the close of business
on February 5, 2019.
The directors indicated an expected dividend for the full year of 2019
of $1.64 per share on the $.10 par value Common Stock of the
corporation, subject to the normal quarterly review by the Board.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com
or follow us on LinkedIn,